A significant difference is one makes a difference

Academic Emergency Medicine

Volumn 4, Issue 10, 1997, Pages 936-938

  Todd, Knox H ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Antidote; Benzodiazepine; Clinical trial; Fiumazen ; Significant difference

Indexed keywords

ANTIDOTE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; FLUMAZENIL; INTRAVENOUS ANESTHETIC AGENT; MIDAZOLAM;

CLINICAL TRIAL; CONSCIOUS SEDATION; DRUG ANTAGONISM; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; HUMAN; METHODOLOGY; NOTE; PAIN; PRACTICE GUIDELINE; STANDARD; UNITED STATES;

ANESTHETICS, INTRAVENOUS; ANTIDOTES; BENZODIAZEPINES; CLINICAL TRIALS; CONSCIOUS SEDATION; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FLUMAZENIL; HUMANS; MIDAZOLAM; PAIN; PRACTICE GUIDELINES; UNITED STATES;

EID: 0031254120     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1997.tb03654.x     Document Type: Article

References (6)

1. Chiidnofsky CR. for the Emergency Medicine Conscious Sedation Study Group. Safety and efficacy of flumazenii in reversing conscious sedation in the emergency department. Acad Emerg Mad. 1997; 4:944-50.
2. Sackett DL, Haynes RB, Guyatt GH, et aï. Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd edition. Boston, MA: Little, Brown, 1991, pp 198-221.
3. Diamond GA, Denton TA. Alternative perspectives on the biased foundations of medical technology assessment. Ann Intern Ivied. '993; 118:455-64.
4. Strainer DL, Norman OR. Health Measurement Scales: A Practical Guide to Their Development and Use, 2nd edition. Cambridge, UK: Oxford University Press, 1995, pp 7980.
5. McCloy RF. Reversal of conscious sedation by fiumazenil: current status and future prospects. Acta Anaesthesiol Scand. 1995; 39(suppi 108):35-42.
6. Paris PM. Relationship between academia and industry: ethical considerations. Ann Emerg Med. 1996:27:416-7.